Tweets from WIPO SCCR 18
Several people are reporting from the WIPO SCCR 18 meeting on Twitter. Some but not all use a hash tag #sccr18, for those familiar with the twitter search system. Below are the 60 tweets I posted so far.
Search Results for: car t
Brazil, Ecuador and Paraguay submit proposal on a WIPO Treaty for Reading Disabled Persons
On Monday, 25 May 2009, the governments of Brazil, Ecuador and Paraguay submitted a proposal to the to the 18th Session of the WIPO Standing Committee on Copyright and Related Rights (SCCR) entitled, “Proposal by Brazil, Ecuador and Paraguay, relating to Limitations and Exceptions: Treaty proposed by the World Blind Union (WBU)”. Continue Reading
Conclusions Montevideo Meeting on WIPO WBU Treaty proposal
On 13-14 May 2009, representatives from 10 Latin American and Caribbean governments, representatives from blind organizations and nongovernmental organizations met in Montevideo (Uruguay) to analyze the World Blind Union (WBU) proposal for a WIPO treaty for the blind, visually impaired and other reading disabled persons.
WHA: Statement by the Government of Bolivia
This is the statement that the government of Bolivia delivered today to the 62nd World Health Assembly at the conclusion of the discussions on the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property (WHA 61.21).
Statement of Bolivia on resolving outstanding elements of agenda item 12.8
Joint Statement on behalf of
Bangladesh, Barbados, Bolivia and Suriname, and
Cuba, Ecuador, Nicaragua and Venezuela
WHA to take up IGWG resolution 9am Friday
The WHA will take up the WHA IGWG resolution at 9AM on Friday.
When discussing the issue of excluding the WHO from discussions about a medical R&D treaty, one PhRMA lobbyist told me “this was put to bed long ago.” He was in part referring to a WHO “green room” meeting that was organized before the Obama inauguration. One negotiator said the pharmaceutical companies are pressing hard to kill the medical R&D treaty here “before the new people take over.”
WHO at a crossroads on a mandate for an R&D Treaty
21 May 2009
Today at the World Health Assembly (WHA) the US and EU are opposing that the WHO have a mandate on global research and development norms, including the possibility for Member States to negotiate at WHO a global biomedical R&D treaty.
Developing countries governments made very strong interventions this morning on this issue (among them India, Bolivia, Barbados, Suriname, Bangladesh, Ghana, Argentina, Venezuela, Nicaragua, Ecuador, Cuba and Jamaica) and are wondering where are the promises of multilateralism made by the new Obama administration.
Soundproof books
I spent a few minutes today on Amazon, to check on reports that some Kindle titles now have text to speech disabled. Among the authors who are “turning off” text to speech in Kindle editions of books are President Obama, Vice President Biden, Toni Morrison, the Pope, Stephen King, Maya Angelou, Mother Teresa, Isaac Asimov, Tom Brokaw, P.D. James, Robert B. Reich, George Will and Ann Coulter, to mention a few.
Submissions of Member States and Stakeholders to WHO Expert Working Group on R&D Financing
The contributions from WHO Member States and other Stakeholders to the Expert Working Group on R&D financing are now available on the WHO website.
The following extract is taken from the WHO public hearing website:
GRULAC recommendations to Working Group to the PCT Assembly
Today is day four of the second session of the International Patent Cooperation Union (PCT) Working Group of the Patent Cooperation Treaty (PCT) taking place at WIPO. Here below are the suggestions of the Group of Latin American and Caribbean Member States (GRULAC) would like to be incorporated into the recommendation of the Working Group to the PCT Assembly.The Members of GRULAC that are contracting-parties to the PCT Treaty suggest the addition of the following elements into the recommendation of the Working Group to the PCT Assembly.
Microsoft: What can go wrong
MICROSOFT CORPORATION, FORM 10-Q For the Quarter Ended March 31, 2009
Item 1A. Risk Factors
Our operations and financial results are subject to various risks and uncertainties, including those described below, that could adversely affect our business, financial condition, results of operations, cash flows, and the trading price of our common stock.